Long-term control and partial remission after initial pseudoprogression of glioblastoma by anti-PD-1 treatment with nivolumab. [electronic resource]
Producer: 20190708Description: 454-456 p. digitalISSN:- 1523-5866
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents, Immunological -- therapeutic use
- Disease Progression
- Drug Therapy, Combination
- Glioblastoma -- drug therapy
- Humans
- Immunotherapy
- Middle Aged
- Nivolumab -- therapeutic use
- Prognosis
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Remission Induction
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.